These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 17425222)

  • 1. The direct and indirect costs of untreated insomnia in adults in the United States.
    Ozminkowski RJ; Wang S; Walsh JK
    Sleep; 2007 Mar; 30(3):263-73. PubMed ID: 17425222
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The direct costs of untreated comorbid insomnia in a managed care population with major depressive disorder.
    Asche CV; Joish VN; Camacho F; Drake CL
    Curr Med Res Opin; 2010 Aug; 26(8):1843-53. PubMed ID: 20515321
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Direct and Indirect Healthcare Resource Utilization and Costs Among Migraine Patients in the United States.
    Bonafede M; Sapra S; Shah N; Tepper S; Cappell K; Desai P
    Headache; 2018 May; 58(5):700-714. PubMed ID: 29446063
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Health benefit costs and absenteeism due to insomnia from the employer's perspective: a retrospective, case-control, database study.
    Kleinman NL; Brook RA; Doan JF; Melkonian AK; Baran RW
    J Clin Psychiatry; 2009 Aug; 70(8):1098-104. PubMed ID: 19758521
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The economic burden of insomnia: direct and indirect costs for individuals with insomnia syndrome, insomnia symptoms, and good sleepers.
    Daley M; Morin CM; LeBlanc M; Grégoire JP; Savard J
    Sleep; 2009 Jan; 32(1):55-64. PubMed ID: 19189779
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Societal burden of cluster headache in the United States: a descriptive economic analysis.
    Ford JH; Nero D; Kim G; Chu BC; Fowler R; Ahl J; Martinez JM
    J Med Econ; 2018 Jan; 21(1):107-111. PubMed ID: 29125368
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-effectiveness of eszopiclone for the treatment of adults with primary chronic insomnia.
    Snedecor SJ; Botteman MF; Bojke C; Schaefer K; Barry N; Pickard AS
    Sleep; 2009 Jun; 32(6):817-24. PubMed ID: 19544759
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Costs of asthma among US working adults.
    Shenolikar R; Song X; Anderson JA; Chu BC; Cantrell CR
    Am J Manag Care; 2011 Jun; 17(6):409-16. PubMed ID: 21756011
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Direct and Indirect Costs Among United States Commercially Insured Employees With Migraine.
    Gilligan AM; Foster SA; Sainski-Nguyen A; Sedgley R; Smith D; Morrow P
    J Occup Environ Med; 2018 Dec; 60(12):1120-1127. PubMed ID: 30199470
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The direct and indirect cost burden of Crohn's disease and ulcerative colitis.
    Gibson TB; Ng E; Ozminkowski RJ; Wang S; Burton WN; Goetzel RZ; Maclean R
    J Occup Environ Med; 2008 Nov; 50(11):1261-72. PubMed ID: 19001952
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Will insomnia treatments produce overall cost savings to commercial managed-care plans? A predictive analysis in the United States.
    Jhaveri M; Seal B; Pollack M; Wertz D
    Curr Med Res Opin; 2007 Jun; 23(6):1431-43. PubMed ID: 17559740
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The economic consequences of irritable bowel syndrome: a US employer perspective.
    Leong SA; Barghout V; Birnbaum HG; Thibeault CE; Ben-Hamadi R; Frech F; Ofman JJ
    Arch Intern Med; 2003 Apr; 163(8):929-35. PubMed ID: 12719202
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cost effectiveness of long-term treatment with eszopiclone for primary insomnia in adults: a decision analytical model.
    Botteman MF; Ozminkowski RJ; Wang S; Pashos CL; Schaefer K; Foley DJ
    CNS Drugs; 2007; 21(4):319-34. PubMed ID: 17381185
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Direct and indirect healthcare resource utilization and costs associated with ulcerative colitis in a privately-insured employed population in the US.
    Cohen R; Skup M; Ozbay AB; Rizzo J; Yang M; Diener M; Chao J
    J Med Econ; 2015 Jun; 18(6):447-56. PubMed ID: 25728698
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insomnia and absenteeism at work. Who pays the cost?
    Godet-Cayré V; Pelletier-Fleury N; Le Vaillant M; Dinet J; Massuel MA; Léger D
    Sleep; 2006 Feb; 29(2):179-84. PubMed ID: 16494085
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Direct and indirect costs associated with Dupuytren's contracture.
    Macaulay D; Ivanova J; Birnbaum H; Sorg R; Skodny P
    J Med Econ; 2012; 15(4):664-71. PubMed ID: 22369346
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insomnia-related comorbidities and economic costs among a commercially insured population in the United States.
    Pollack M; Seal B; Joish VN; Cziraky MJ
    Curr Med Res Opin; 2009 Aug; 25(8):1901-11. PubMed ID: 19530979
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Health economics of insomnia therapy: implications for policy.
    Botteman M
    Sleep Med; 2009 Sep; 10 Suppl 1():S22-5. PubMed ID: 19647482
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Insomnia risks and costs: health, safety, and quality of life.
    Rosekind MR; Gregory KB
    Am J Manag Care; 2010 Aug; 16(8):617-26. PubMed ID: 20712395
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The direct economic costs of insomnia in the United States for 1995.
    Walsh JK; Engelhardt CL
    Sleep; 1999 May; 22 Suppl 2():S386-93. PubMed ID: 10394612
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.